Stay updated on Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, tolerability, and efficacy of INCAGN01949 in combination with immune therapies for participants with advanced or metastatic malignancies.
    Difference
    0.1%
    Check dated 2024-06-06T14:36:37.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying inclusion and exclusion criteria for participants with advanced or metastatic disease. This change provides more specific information about the health conditions and prior treatments required for study participation.
    Difference
    22%
    Check dated 2024-05-22T21:10:14.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:27:03.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.